Clinical Trials Logo
  1. Home
  2. Microalbuminuria
  3. NCT01891292

Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy

Microalbuminuria Clinical Trial

Official title:
A Phase 2 Study of the Efficacy of Antioxidant Therapy Compared With Enalapril in Slowing the Progression of Sickle Nephropathy in Children

Clinical Trial Summary

The purpose of this study is to determine whether enalapril or antioxidant therapy (N-Acetylcysteine) is effective in reducing microalbuminuria in children with sickle cell disease and and its progression to sickle nephropathy

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01891292
Study type Interventional
Source The University of The West Indies
Contact Lesley King, MB.BS
Phone 976-927-2471
Email lesley.king@uwimona.edu.jm
Status Not yet recruiting
Phase N/A
Start date July 2013
Completion date September 2015
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT05016440 - Lisinopril for Renal Protection in Postpartum Preeclamptic Women N/A
Completed NCT00320879 - Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria Phase 4
Recruiting NCT01230034 - Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria Phase 3
Completed NCT02122731 - Amiloride for Resistant Hypertension Phase 4
Completed NCT03889236 - Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. N/A
Recruiting NCT03016910 - Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus. N/A
Terminated NCT00458081 - Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors Phase 3
Recruiting NCT00427271 - Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients Phase 4
Enrolling by invitation NCT02462369 - Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients Phase 4
Recruiting NCT02068833 - Resolution of Microalbuminuria and Dysmetabolism Following Bariatric Surgery: Prospective Study N/A
Completed NCT00550095 - To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus Phase 4
Completed NCT03089333 - Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects Phase 4
Completed NCT00907374 - Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria N/A
Completed NCT03470454 - Contrast Nephropathy in Type 2 Diabetes
Recruiting NCT02409511 - Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy) N/A
Terminated NCT02048904 - Use of Sitagliptin to Decrease Microalbuminuria Phase 4
Completed NCT00484068 - Chicken-Diet vs. Enalapril to Reduce Albuminuria N/A
Completed NCT01552954 - Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan Phase 4
Recruiting NCT04025996 - REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus
Not yet recruiting NCT02808845 - Microalbuminuria Predicting CIAKI After CAG N/A